People with MDS often face two serious problems at once: impaired blood cell production and weakening bones. Researchers in Dresden have now tested a drug that could potentially target both conditions at the same time.
Good Newsletter von DieSachsen.de
Good Newsletter von DieSachsen.de
Articles are loaded
Your data is important to us and we would like to use cookies to further improve your incredible experience on DieSachsen.de.
